Viyash Scientific Ltd (VIYASH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 213056, "name": "Viyash Scientifi", "stock_name": "Viyash Scientifi", "full_name": "Viyash Scientific Ltd", "name_url": "stocks-analysis/viyash-scientifi", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "188.45", "chg": -1.45, "chgp": "-0.76%", "dir": -1, "prev_price": "189.90", "mcapval": "8,429.00 Cr", "mcap": "Small Cap", "scripcode": 512529, "symbol": "VIYASH", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE807F01027", "curr_date": "Mar 20", "curr_time": "", "bse_nse_vol": "5.56 lacs", "exc_status": "Active", "traded_date": "Mar 20, 2026", "traded_date_str": "2026 03 20", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/viyash-scientifi-213056-0&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MN", "url": "https://www.marketsmojo.com/mojopro/strategy/2", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/viyash-scientifi-213056-0&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Viyash Scientific Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/viyash-scientific-ltd-is-rated-hold-3896409", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ViyashScientifi_mojoScore_3896409.png", "date": "2026-03-17 10:10:02", "description": "Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 19 January 2026. While this rating change occurred in January, the analysis and financial metrics discussed here reflect the company’s current position as of 17 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Viyash Scientific Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/viyash-scientific-ltd-is-rated-hold-by-marketsmojo-3875723", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ViyashScientifi_mojoScore_3875723.png", "date": "2026-03-06 10:10:02", "description": "Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 19 Jan 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Viyash Scientific Ltd Hits Intraday Low Amid Price Pressure on 2 March 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/viyash-scientific-ltd-hits-intraday-low-amid-price-pressure-on-2-march-2026-3865368", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ViyashScientifi_priceRelatedfactors_3865368.png", "date": "2026-03-02 13:55:47", "description": "Viyash Scientific Ltd experienced a significant intraday decline on 2 Mar 2026, touching a low of Rs 195.7, down 7.97% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and subdued market sentiment within the Pharmaceuticals & Biotechnology space." }, { "title": "Viyash Scientific Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/viyash-scientific-ltd-is-rated-hold-by-marketsmojo-3850915", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ViyashScientifi_mojoScore_3850915.png", "date": "2026-02-23 10:10:05", "description": "Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 February 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Viyash Scientific Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/viyash-scientific-ltd-is-rated-hold-3834992", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ViyashScientifi_mojoScore_3834992.png", "date": "2026-02-12 10:10:03", "description": "Viyash Scientific Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 February 2026, providing investors with the most up-to-date insight into the stock’s performance and outlook." }, { "title": "Viyash Scientific Ltd Declines 1.42% Despite Record Quarterly Results: 3 Key Factors Behind the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/viyash-scientific-ltd-declines-142-despite-record-quarterly-results-3-key-factors-behind-the-weeks-volatility-3827434", "imagepath": "", "date": "2026-02-08 13:00:14", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Stock opens at Rs.203.60, down 0.44% amid broader market weakness</p>\n <p><strong>3 Feb:</strong> Sharp rebound to Rs.213.00 (+4.62%) following positive market sentiment</p>\n <p><strong>4 Feb:</strong> Continued gains to Rs.216.75 (+1.76%) ahead of quarterly results</p>\n <p><strong>5 Feb:</strong> Profit-taking leads to Rs.209.05 close (-3.55%)</p>\n <p><strong>6 Feb:</strong> Quarterly results announced; stock closes at Rs.201.60 (-3.56%) despite strong fundamentals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"sta..." }, { "title": "Are Viyash Scientific Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-viyash-scientific-ltd-latest-results-good-or-bad-3824787", "imagepath": "", "date": "2026-02-06 19:21:21", "description": "Viyash Scientific Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance and profitability challenges. The company reported a record revenue of ₹858.41 crores, reflecting a year-on-year growth of 10.90% and a slight sequential increase of 0.95%. This achievement highlights Viyash Scientific's ability to capture market share within the animal health pharmaceutical sector, despite a moderation in growth compared to previous quarters.\n\nHowever, the net profit for the same period was ₹38.44 crores, which represents a significant decline of 29.99% quarter-on-quarter and a 13.83% decrease year-on-year. This decline raises concerns regarding the sustainability of earnings, particularly as the profit margins have compressed. The PAT margin fell to 5.65%, down from 8.57% in the previous quarter, primarily due to increased tax expenses and higher depreciation charges.\n\nOn the ..." }, { "title": "Viyash Scientific Ltd Reports Outstanding Quarterly Performance Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/viyash-scientific-ltd-reports-outstanding-quarterly-performance-amid-sector-challenges-3824262", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ViyashScientifi_fintrenddot_3824262.png", "date": "2026-02-06 11:00:08", "description": "Viyash Scientific Ltd has delivered an outstanding financial performance in the December 2025 quarter, marking a significant improvement in key metrics such as revenue growth, profitability, and operational efficiency. This robust quarter contrasts with the company’s previous trend and positions it favourably within the Pharmaceuticals & Biotechnology sector, despite a recent dip in share price and broader market volatility." }, { "title": "Viyash Scientific Q3 FY26: Strong Revenue Growth Masks Profit Volatility and Valuation Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/viyash-scientific-q3-fy26-strong-revenue-growth-masks-profit-volatility-and-valuation-concerns-3824248", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ViyashScientifi_quaterlyResult_3824248.png", "date": "2026-02-06 09:32:58", "description": "Viyash Scientific Ltd. (formerly Sequent Scientific Ltd.), a leading integrated pharmaceutical company operating in animal health APIs and formulations, reported its Q3 FY26 results with consolidated net profit declining 29.99% quarter-on-quarter to ₹38.44 crores, despite revenue reaching an all-time high of ₹858.41 crores. The stock, trading at ₹200.85 with a market capitalisation of ₹9,121 crores, has declined 3.92% following the results announcement, reflecting investor concerns over profit volatility and stretched valuations at 206x P/E ratio." } ], "total": 237, "sid": "213056", "stock_news_url": "https://www.marketsmojo.com/news/viyash-scientific-213056" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "13-Mar-2026", "details": "Scrutinizers Report and Voting Results", "source": "BSE" }, { "caption": "Report On Distribution Of Sale Proceeds Of Fractional Shares", "datetime": "10-Mar-2026", "details": "Report of Audit Committee and Independent Directors of the Company certifying the distribution of sale proceeds of fractional shares to eligible shareholders", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS", "datetime": "26-Feb-2026", "details": "ESOP Allotment", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Viyash Scientific Ltd has declared <strong>25%</strong> dividend, ex-date: 08 Sep 21", "dt": "2021-09-08", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Viyash Scientific Ltd has announced <strong>2:10</strong> stock split, ex-date: 25 Feb 16", "dt": "2016-02-25", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Stock opens at Rs.203.60, down 0.44% amid broader market weakness

3 Feb: Sharp rebound to Rs.213.00 (+4.62%) following positive market sentiment

4 Feb: Continued gains to Rs.216.75 (+1.76%) ahead of quarterly results

5 Feb: Profit-taking leads to Rs.209.05 close (-3.55%)

6 Feb: Quarterly results announced; stock closes at Rs.201.60 (-3.56%) despite strong fundamentals

Read full news article

Are Viyash Scientific Ltd latest results good or bad?

2026-02-06 19:21:21

Viyash Scientific Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance and profitability challenges. The company reported a record revenue of ₹858.41 crores, reflecting a year-on-year growth of 10.90% and a slight sequential increase of 0.95%. This achievement highlights Viyash Scientific's ability to capture market share within the animal health pharmaceutical sector, despite a moderation in growth compared to previous quarters. However, the net profit for the same period was ₹38.44 crores, which represents a significant decline of 29.99% quarter-on-quarter and a 13.83% decrease year-on-year. This decline raises concerns regarding the sustainability of earnings, particularly as the profit margins have compressed. The PAT margin fell to 5.65%, down from 8.57% in the previous quarter, primarily due to increased tax expenses and higher depreciation charges. On the ...

Read full news article

Viyash Scientific Ltd Reports Outstanding Quarterly Performance Amid Sector Challenges

2026-02-06 11:00:08

Viyash Scientific Ltd has delivered an outstanding financial performance in the December 2025 quarter, marking a significant improvement in key metrics such as revenue growth, profitability, and operational efficiency. This robust quarter contrasts with the company’s previous trend and positions it favourably within the Pharmaceuticals & Biotechnology sector, despite a recent dip in share price and broader market volatility.

Read full news article

Viyash Scientific Q3 FY26: Strong Revenue Growth Masks Profit Volatility and Valuation Concerns

2026-02-06 09:32:58

Viyash Scientific Ltd. (formerly Sequent Scientific Ltd.), a leading integrated pharmaceutical company operating in animal health APIs and formulations, reported its Q3 FY26 results with consolidated net profit declining 29.99% quarter-on-quarter to ₹38.44 crores, despite revenue reaching an all-time high of ₹858.41 crores. The stock, trading at ₹200.85 with a market capitalisation of ₹9,121 crores, has declined 3.92% following the results announcement, reflecting investor concerns over profit volatility and stretched valuations at 206x P/E ratio.

Read full news article